Saphnelo (anifrolumab-fnia) - AstraZeneca
Recombinant Zoster Vaccine Protects Against Both Herpes Zoster and COVID-19 Infection in SLE Patients on Anifrolumab (ACR Convergence 2026) - Sep 8, 2026 - Abstract #2669; Pres time: Nov 10, 2026; 10:30 AM - 12:30 PM; Location: WB1&2; In Person; No abstract available 
Clinical • Herpes Zoster • Infectious Disease • Inflammatory Arthritis • Novel Coronavirus Disease • Varicella Zoster
https://eppro02.ativ.me/web/page.php?nav=false&page=Session&project=ACR26&id=3570117
 
Binod Kc, MBBS
 
Sep 8, 2026
 
Prev Next